Severance Hospital Begins Stem Cell Clinical Trial for Knee Osteoarthritis
Selected for Ministry of Health Advanced Regenerative Medicine Project
Multi-center Clinical Trial for 165 Patients
Efficacy of Autologous Adipose-derived Stem Cells to Be Verified
Severance Hospital announced on July 24 that it has been selected for the "2026 2nd Advanced Regenerative Medicine Clinical Research Activation Support Project," overseen by the Regenerative Medicine Promotion Foundation under the Ministry of Health and Welfare.
As the lead institution, Severance Hospital will conduct a multi-center clinical study together with Seoul National University Hospital and Inha University Hospital to evaluate the efficacy and safety of stem cell therapy for patients with knee osteoarthritis. The study will be overseen by Professor Kim Sunghwan from the Department of Orthopedic Surgery at Yonsei University College of Medicine.
The research team will receive approximately 2.9 billion won in funding over 21 months and plans to recruit 165 patients. Mesenchymal stem cells harvested from each patient's own adipose tissue will be injected into the knee joint cavity to assess improvements in pain and the potential for cartilage regeneration.
The clinical trial will be conducted as a randomized, double-blind, placebo-controlled study. Both participants and medical staff will be blinded as to whether the patient is receiving stem cell therapy, in order to objectively verify the treatment's effectiveness.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Kim stated, "We will verify the safety and efficacy of this therapy in order to overcome the limitations of conventional treatments and expand the treatment options available to patients with osteoarthritis."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.